STOCK TITAN

Invivyd (IVVD) officer sells 37,256 and 30,706 shares under 10b5-1 plan

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) reported insider equity activity by Chief Legal Officer and Secretary Jill Andersen involving the vesting of 170,000 Restricted Stock Units, each converting into one share of common stock. On August 17, 2026, 37,256 shares of common stock were sold at a weighted average price of $0.722 per share in transactions priced between $0.682 and $0.830. On August 18, 2026, a further 30,706 shares were sold at a weighted average price of $0.8429 per share in transactions priced between $0.760 and $0.872. The sales were described as non-discretionary “sell-to-cover” transactions to satisfy tax withholding obligations upon RSU vesting, conducted under a Rule 10b5-1 plan adopted on February 20, 2025. Following these transactions, an additional 500 shares of common stock are reported as held indirectly by Andersen’s spouse.

Positive

  • None.

Negative

  • None.
Insider Andersen Jill
Role Chief Legal Officer, Secretary
Sold 67,962 shs ($53K)
Approx. gross sale proceeds $53K
Type Security Shares Price Value
Sale Common Stock F2, F4 30,706 $0.8429 $26K
Sale Common Stock F2, F3 37,256 $0.722 $27K
Exercise Restricted Stock Units F1, F5 170,000 $0.00 $0.00
Exercise Common Stock F1 170,000 -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 283,774 shares (Direct); Common Stock — 500 shares (Indirect, By spouse)
Footnotes (5)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
RSUs Converted 170,000 shares Restricted Stock Units converting into common stock on August 15, 2026
Shares Sold 2026-08-17 37,256 shares Common stock sold at weighted average price of $0.722 per share
Weighted Average Price 2026-08-17 $0.722 per share Sales in price range $0.682–$0.830
Shares Sold 2026-08-18 30,706 shares Common stock sold at weighted average price of $0.8429 per share
Weighted Average Price 2026-08-18 $0.8429 per share Sales in price range $0.760–$0.872
RSU Vesting Period 18 months One-third of RSUs vesting every six months from February 15, 2025
Indirect Spouse Holding 500 shares Common stock held indirectly by spouse after reported transactions
10b5-1 Plan Adoption Date February 20, 2025 Plan governing non-discretionary sell-to-cover tax sales
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 plan regulatory
"sell-to-cover transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
sell-to-cover financial
"shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
weighted average price financial
"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

What insider transactions did Invivyd (IVVD) report for Jill Andersen in this Form 4?

Jill Andersen reported 170,000 RSUs converting into common stock, followed by sales of 37,256 shares on August 17, 2026 and 30,706 shares on August 18, 2026 in open-market style transactions.

How many Invivyd (IVVD) shares did Jill Andersen sell and at what prices?

Andersen sold 37,256 shares at a weighted average of $0.722 and 30,706 shares at a weighted average of $0.8429, with trade prices ranging from $0.682–$0.830 and $0.760–$0.872, respectively.

Were Jill Andersen’s Invivyd (IVVD) stock sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were made in non-discretionary “sell-to-cover” transactions under a Rule 10b5-1 plan adopted on February 20, 2025, to satisfy tax withholding obligations on RSU vesting.

What are the terms of Jill Andersen’s Invivyd (IVVD) RSU award mentioned in the Form 4?

The RSU award of 170,000 units vests over 18 months, with one-third vesting every six months after the grant date of February 15, 2025, subject to continued service on each vesting date.

Does Jill Andersen report any indirect holdings of Invivyd (IVVD) shares?

Yes. The Form 4 reports 500 shares of Invivyd common stock held indirectly “By spouse”, indicating ownership is attributed through her spouse rather than directly in her own name.

What role does Jill Andersen hold at Invivyd (IVVD) in connection with this Form 4?

Jill Andersen is identified as an officer of Invivyd, Inc., serving as Chief Legal Officer and Secretary, and the reported transactions relate to her equity compensation and associated tax withholding sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Andersen Jill

(Last)(First)(Middle)
C/O INVIVYD, INC.
205 CHURCH STREET

(Street)
NEW HAVEN CONNECTICUT 06510

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer, Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/15/2026M170,000A(1)351,736D
Common Stock08/17/2026S37,256(2)D$0.722(3)314,480D
Common Stock08/18/2026S30,706(2)D$0.8429(4)283,774D
Common Stock500IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/15/2026M170,000 (5) (5)Common Stock170,000$0.000D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)